- Home
- CNSP vs ATCH Comparison
CNSP vs ATCH Comparison
Compare CNSP & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- ATCH
- Stock Information
- Founded
- CNSP 2017
- ATCH 2022
- Country
- CNSP United States
- ATCH United States
- Employees
- CNSP N/A
- ATCH N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- ATCH
- Sector
- CNSP Health Care
- ATCH
- Exchange
- CNSP Nasdaq
- ATCH Nasdaq
- Market Cap
- CNSP 5.4M
- ATCH 5.2M
- IPO Year
- CNSP 2019
- ATCH N/A
- Fundamental
- Price
- CNSP $0.11
- ATCH $0.21
- Analyst Decision
- CNSP Strong Buy
- ATCH
- Analyst Count
- CNSP 1
- ATCH 0
- Target Price
- CNSP $0.50
- ATCH N/A
- AVG Volume (30 Days)
- CNSP 6.2M
- ATCH 1.9M
- Earning Date
- CNSP 11-15-2024
- ATCH 11-15-2024
- Dividend Yield
- CNSP N/A
- ATCH N/A
- EPS Growth
- CNSP N/A
- ATCH N/A
- EPS
- CNSP N/A
- ATCH 0.04
- Revenue
- CNSP N/A
- ATCH N/A
- Revenue This Year
- CNSP N/A
- ATCH N/A
- Revenue Next Year
- CNSP N/A
- ATCH N/A
- P/E Ratio
- CNSP N/A
- ATCH $4.56
- Revenue Growth
- CNSP N/A
- ATCH N/A
- 52 Week Low
- CNSP $0.10
- ATCH $0.12
- 52 Week High
- CNSP $71.00
- ATCH $10.26
- Technical
- Relative Strength Index (RSI)
- CNSP 49.04
- ATCH 52.39
- Support Level
- CNSP $0.10
- ATCH $0.18
- Resistance Level
- CNSP $0.12
- ATCH $0.24
- Average True Range (ATR)
- CNSP 0.01
- ATCH 0.02
- MACD
- CNSP 0.00
- ATCH -0.00
- Stochastic Oscillator
- CNSP 56.90
- ATCH 47.31
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About ATCH AtlasClear Holdings Inc. Common Stock
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.